Visualitza HVH - Articles científics per autor "Kapur, Gaurav"
Ara mostrant els elements 1-1 d 1
-
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment
Dixon, Bradley; Kim, Seong Heon; Kapur, Gaurav; Mauch, Teri; Ortiz, Stephan; Ariceta Iraola, Gema (Elsevier, 2021-07)